PGR and neoplasm: The tumor was positive for Rb, p53 (1-2%) and negative for estrogen receptor (ER) and progesterone receptor (PR) and had a higher MIB-1 (Ki-67) proliferation marker count (50%) (Figures 1(a) and 1(b)).